community download

The Netherlands: How to anticipate future pharma and healthcare dynamics?

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

 

Cornelis Boersma, Head of New Products & Market Entry,GlaxoSmithKline, explores in this presentation:

  • Trends in healthcare and pharma expenditures
  • Dutch Pharma system under development
  • NL policy: Implementation of ‘Vuvuzela’
  • Market Access and Market Access hurdles
  • Conditional instruments for drug innovations
  • Market vs central regulation?
  • Future perspectives